Skip to Main Content

Author Details

Timothy R Rebbeck
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
1991
466
86
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37563423The role of community outreach and engagement in evaluation of NCI Cancer Center Support Grants.Cancer Causes Control2024
37713266Prostate cancer screening in African American men: a review of the evidence.J Natl Cancer Inst2024
36791345Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network.Cancer Epidemiol Biomarkers Prev2023
37961155Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves cross-ancestry prediction.medRxiv2023
37886553Heterogeneous genetic architectures and evolutionary genomics of prostate cancer in Sub-Saharan Africa.Res Sq2023
37498602Disparities in Travel-Related Barriers to Accessing Health Care From the 2017 National Household Travel Survey.JAMA Netw Open2023
37536846Translational Epidemiology: Genetic Ancestry in Breast Cancer: What Is the Role of Genetic Ancestry and Socioeconomic Status in Triple-Negative Breast Cancer?Adv Surg2023
37220318Germline Testing Around the Globe: Challenges in Different Practice Settings.Am Soc Clin Oncol Educ Book2023
37219371Cancer equity for those impacted by mass incarceration.J Natl Cancer Inst2023
37249585Associations between Etiologic or Prognostic Tumor Tissue Markers and Neighborhood Contextual Factors in Male Health Professionals Diagnosed with Prostate Cancer.Cancer Epidemiol Biomarkers Prev2023
37248397Understanding inequities in precision oncology diagnostics.Nat Cancer2023
36945459Variant-specific Mendelian Risk Prediction Model.bioRxiv2023
37139568Influence of Neighborhood Social and Natural Environment on Prostate Tumor Histology in a Cohort of Male Health Professionals.Am J Epidemiol2023
36924580Referral practices of recent graduate and experienced physiotherapists working in Australian primary care for people with musculoskeletal conditions.Musculoskelet Sci Pract2023
36688725Risk prediction models for endometrial cancer: development and validation in an international consortium.J Natl Cancer Inst2023
36872133Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.Eur Urol2023
36418803Risk factors for endometrial cancer in Black women.Cancer Causes Control2023
36759298Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations.Urol Oncol2023
33303244Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer.Eur Urol2022
35550267Cancer in sub-Saharan Africa: a Lancet Oncology Commission.Lancet Oncol2022
35549306Reply to V. Fallet et al.J Clin Oncol2022
35350915Prostate Cancer Screening, Diagnostic, Treatment Procedures and Costs in Sub-Saharan Africa: A Situational Analysis.Cancer Control2022
35801699Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.Elife2022
35344689Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.Lancet Haematol2022
35468227Current and projected number of years of life lost due to prostate cancer: A global study.Prostate2022
35638719Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017.Cancer Med2022
35638091Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race.Eur Urol Open Sci2022
35534567The distinct impacts of race and genetic ancestry on health.Nat Med2022
35759080Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting.Cancer Causes Control2022
35755401A Framework for Promoting Diversity, Equity, and Inclusion in Genetics and Genomics Research.JAMA Health Forum2022
35420316Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer.Breast Cancer Res Treat2022
35715489The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer.NPJ Precis Oncol2022
35623016Toward Equitable Access to Tertiary Cancer Care in Rwanda: A Geospatial Analysis.JCO Glob Oncol2022
36068272Is early-onset cancer an emerging global epidemic? Current evidence and future implications.Nat Rev Clin Oncol2022
36100952Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa.Genome Biol2022
36037186Relative impact of genetic ancestry and neighborhood socioeconomic status on all-cause mortality in self-identified African Americans.PLoS One2022
35925976Evaluating the geographic distribution of cervical cancer patients presenting to a multidisciplinary gynecologic oncology clinic in Gaborone, Botswana.PLoS One2022
36126958Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men.Cancer Epidemiol Biomarkers Prev2022
36225661What Geohistory Can Teach Us About Fundamental Causes of Health Inequities.Health Equity2022
36053178Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive Disease.J Natl Cancer Inst2022
36395437Distance to Multidisciplinary Team Clinic in Gaborone, Botswana, and Stage at Cervical Cancer Presentation for Women Living With and Without HIV.JCO Glob Oncol2022
36256648Prevalence of multimorbidity in men of African descent with and without prostate cancer in Soweto, South Africa.PLoS One2022
36252158Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap.JCO Glob Oncol2022
35320352Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies.Cancer Epidemiol Biomarkers Prev2022
35255255Impact of neighborhood socioeconomic status, income segregation, and greenness on blood biomarkers of inflammation.Environ Int2022
35314469Retrospective analysis to describe trends in first-ever prostate-specific antigen (PSA) testing for primary healthcare facilities in the Gauteng Province, South Africa, between 2006 and 2016.BMJ Open2022
35247879Racial Disparities in Prostate Cancer: Evaluation of Diet, Lifestyle, Family History, and Screening Patterns.Cancer Epidemiol Biomarkers Prev2022
35183359American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review of evidence.Gastrointest Endosc2022
35183358ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations.Gastrointest Endosc2022
35031163A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.Eur Urol2022
  • 1 - 50 of 466

Recommended Authors

SLR Consulting (Canada) Ltd
Career Start Year 2012
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 48
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 33
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 47
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 32
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 26
National Cancer Institute
Career Start Year 2003
Number of shared co-authors 102
National Cancer Institute, National Institute of Health, 9 Medical Center Drive
Career Start Year 2002
Number of shared co-authors 102
Queen's University
Career Start Year 2002
Number of shared co-authors 9
Institute for Human Genetics, University of California San Francisco (UCSF)
Career Start Year 2001
Number of shared co-authors 98
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 62
National Cancer Institute, National Institutes of Health
Career Start Year 1999
Number of shared co-authors 25
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 63
National Institutes of Health
Career Start Year 1998
Number of shared co-authors 12
Southern California Permanente Medical Group
Career Start Year 1998
Number of shared co-authors 5
Vanderbilt University Medical Center
Career Start Year 1996
Number of shared co-authors 120
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Career Start Year 1996
Number of shared co-authors 8
Inc. San Carlos
Career Start Year 1993
Number of shared co-authors 36
National Center for Advancing Translational Sciences
Career Start Year 1993
Number of shared co-authors 12
Institut de Recherche en Cancerologie de Montpellier
Career Start Year 1993
Number of shared co-authors 26
Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 106
University of California los angeles
Career Start Year 1991
Number of shared co-authors 14
Institute of Cancer Research
Career Start Year 1991
Number of shared co-authors 104
Spanish National Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 64
National Cancer Institute, National Institutes of Health
Career Start Year 1987
Number of shared co-authors 127
Baylor College of Medicine
Career Start Year 1986
Number of shared co-authors 179
Peter MacCallum Cancer Centre
Career Start Year 1982
Number of shared co-authors 62
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 88
National Cancer Institute
Career Start Year 1977
Number of shared co-authors 51
University of Washington
Career Start Year 1975
Number of shared co-authors 31

Collaborators

Co-authored papers 69
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 64
University of Cambridge
Co-authored papers 60
Mayo Clinic
Co-authored papers 58
Dana-Farber Cancer Institute
Co-authored papers 54
QIMR Berghofer Medical Research Institute
Co-authored papers 48
QIMR Berghofer Medical Research Institute
Co-authored papers 48
The Institute of Cancer Research
Co-authored papers 48
Co-authored papers 42
Co-authored papers 40
University of Toronto
Co-authored papers 39
Instituto de Salud Carlos III
Co-authored papers 35
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Co-authored papers 34
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 32
Ospedale Circolo e Fondazione Macchi
Co-authored papers 32
University of Utah
Co-authored papers 29
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 29
QIMR Berghofer Medical Research Institute
Co-authored papers 29
National Cancer Institute, National Institutes of Health
Co-authored papers 29
Pomeranian Medical University
Co-authored papers 28
University of Southern California
Co-authored papers 27
Co-authored papers 27
David Geffen School of Medicine, University of California los angeles
Co-authored papers 27
Guy's and St Thomas' NHS Foundation Trust
Co-authored papers 25
Mayo Clinic
Co-authored papers 23
Co-authored papers 22
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 21
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 20
QIMR Berghofer Medical Research Institute
Co-authored papers 19
University of Southern California
Co-authored papers 19